Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Grazoprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021 4 1
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Ty1 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020 2 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 9 1
Asunaprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 1 1
Excel (.xslx) CSV (.csv)